作者
Elliot Israel, Jeffrey M Drazen, Stephen B Liggett, Homer A Boushey, Reuben M Cherniack, Vernon M Chinchilli, David M Cooper, John V Fahy, James E Fish, Jean G Ford, Monica Kraft, Susan Kunselman, Stephen C Lazarus, ROBERT F LEMANSKE Jr, Richard J Martin, DIANE E McLEAN, Stephen P Peters, Edwin K Silverman, Christine A Sorkness, Stanley J Szefler, Scott T Weiss, Chandri N Yandava
发表日期
2000/7/1
期刊
American journal of respiratory and critical care medicine
卷号
162
期号
1
页码范围
75-80
出版商
American Thoracic Society
简介
Inhaled β -adrenergic agonists are the most commonly used medications for the treatment of asthma although there is evidence that regular use may produce adverse effects in some patients. Polymorphisms of the β2-adrenergic receptor ( β2-AR) can affect regulation of the receptor. Smaller studies examining the effects of such polymorphisms on the response to β -agonist therapy have produced inconsistent results. We examined whether polymorphisms at codon 16 ( β2-AR-16) and codon 27 ( β2-AR-27) of the β2-AR might affect the response to regular versus as-needed use of albuterol by genotyping the 190 asthmatics who had participated in a trial examining the effects of regular versus as needed albuterol use. During the 16-wk treatment period there was a small decline in morning peak expiratory flow in patients homozygous for arginine at B2-AR-16 (Arg/Arg) who used albuterol regularly. This effect …
引用总数
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320245333836495272635256262034262118171781455882
学术搜索中的文章
E Israel, JM Drazen, SB Liggett, HA Boushey… - American journal of respiratory and critical care …, 2000